Mirati Therapeutics, Inc. (MRTX) Buy Target $102.10 Sell Target $113.75

Trade Setup

Buy Target $102.10
Sell Target $113.75

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers. 

 
Trending Ideas
Featured Stocks On The Move
Daily Rundown
Top 3 Stocks in Leading Sectors

  • 3 Bank Stocks To Buy Now

    Central Pacific Financial Corp. (CPF) Central Pacific Financial Corp. is the holding company for Central Pacific Bank, a Hawaii-based financial institution offering banking, lending, and investment services to individuals and... Read More

  • 3 Space Technology Stocks To Buy Now

    Rocket Lab USA, Inc. (RKLB) Rocket Lab USA, Inc. is a leading aerospace company focused on designing and launching small satellites into orbit. Its Electron rocket and Photon spacecraft enable... Read More

  • 3 Consumer Goods Stocks To Buy Now

    Post Holdings, Inc. (POST) Post Holdings, Inc. is a consumer packaged goods company specializing in cereals, snacks, and refrigerated food products. The company owns brands such as Honey Bunches of... Read More

  • 3 Electrical Product Stocks To Buy Now

    EnerSys (ENS) EnerSys is a global leader in stored energy solutions, providing industrial batteries, chargers, and energy systems. The company serves industries like telecommunications, aerospace, and renewable energy with advanced... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    Lantern Pharma Inc. (LTRN) Lantern Pharma Inc. is a clinical-stage biopharmaceutical company focused on AI-driven drug development for cancer treatments. The company utilizes machine learning to identify and advance precision... Read More

  • 3 Telecom Stocks To Buy Now

    Ceragon Networks Ltd. (CRNT) Ceragon Networks Ltd. specializes in wireless backhaul solutions, providing high-capacity broadband connectivity for telecom operators and enterprises. The company enables efficient and scalable network expansion with... Read More

  • 3 Producer Manufacturing Stocks To Buy Now

    Deere & Company (DE) Deere & Company is a global leader in agricultural, construction, and forestry equipment. Known for its John Deere brand, the company provides innovative machinery and technology... Read More

  • 3 Biomedical Stocks To Buy Now

    Trevi Therapeutics, Inc. (TRVI) Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for chronic cough and neurologically mediated conditions. Its lead candidate, Haduvio, is being evaluated... Read More

© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.